NO751362L - - Google Patents
Info
- Publication number
- NO751362L NO751362L NO751362A NO751362A NO751362L NO 751362 L NO751362 L NO 751362L NO 751362 A NO751362 A NO 751362A NO 751362 A NO751362 A NO 751362A NO 751362 L NO751362 L NO 751362L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- lower alkyl
- hydroxy
- denotes
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 35
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 21
- -1 hydroxy, hydroxy Chemical group 0.000 claims description 21
- 125000004432 carbon atom Chemical group C* 0.000 claims description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 15
- 239000003513 alkali Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 229910052736 halogen Inorganic materials 0.000 claims description 13
- 150000002367 halogens Chemical class 0.000 claims description 13
- 229920006395 saturated elastomer Polymers 0.000 claims description 11
- 150000001342 alkaline earth metals Chemical group 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 10
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 150000001340 alkali metals Chemical class 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 125000002723 alicyclic group Chemical group 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000001188 haloalkyl group Chemical group 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical group C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 3
- 125000005233 alkylalcohol group Chemical group 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 9
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- 239000000243 solution Substances 0.000 description 38
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229940093499 ethyl acetate Drugs 0.000 description 14
- 235000019439 ethyl acetate Nutrition 0.000 description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 9
- 238000001704 evaporation Methods 0.000 description 8
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 6
- 238000007792 addition Methods 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- RVMGXWBCQGAWBR-UHFFFAOYSA-N 4-oxo-1-benzopyran-2-carboxylic acid Chemical compound C1=CC=C2OC(C(=O)O)=CC(=O)C2=C1 RVMGXWBCQGAWBR-UHFFFAOYSA-N 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- VEKQSHDKCBTWRO-UHFFFAOYSA-N 4h-chromene-2-carboxylic acid Chemical compound C1=CC=C2OC(C(=O)O)=CCC2=C1 VEKQSHDKCBTWRO-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940117916 cinnamic aldehyde Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- UTNOGEATBASFHA-UHFFFAOYSA-N 5-[2-acetyloxy-3-(2-carboxy-4-oxochromen-5-yl)oxypropoxy]-4-oxochromene-2-carboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(OC(=O)C)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 UTNOGEATBASFHA-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 2
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 2
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- QIRNGVVZBINFMX-UHFFFAOYSA-N 2-allylphenol Chemical compound OC1=CC=CC=C1CC=C QIRNGVVZBINFMX-UHFFFAOYSA-N 0.000 description 1
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 1
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical class C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical group [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- VHVYJCKZGZNKKI-UHFFFAOYSA-N ethyl 2-[2-(2-oxoethyl)phenoxy]acetate Chemical compound CCOC(=O)COC1=CC=CC=C1CC=O VHVYJCKZGZNKKI-UHFFFAOYSA-N 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- QNTJIDDITSYDAK-UHFFFAOYSA-N methyl 2-[2-(3-oxo-1-phenylprop-1-en-2-yl)phenoxy]acetate Chemical compound COC(=O)COC1=CC=CC=C1C(C=O)=CC1=CC=CC=C1 QNTJIDDITSYDAK-UHFFFAOYSA-N 0.000 description 1
- WNVKMIHNAHIVDP-UHFFFAOYSA-N methyl 4-oxochromene-2-carboxylate Chemical compound C1=CC=C2OC(C(=O)OC)=CC(=O)C2=C1 WNVKMIHNAHIVDP-UHFFFAOYSA-N 0.000 description 1
- SQNCAMKGCRBIJA-UHFFFAOYSA-N methyl 6-methyl-4-oxochromene-2-carboxylate Chemical compound CC1=CC=C2OC(C(=O)OC)=CC(=O)C2=C1 SQNCAMKGCRBIJA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- KDBRTIVCOMURGG-UHFFFAOYSA-M sodium;4-oxochromene-2-carboxylate Chemical compound [Na+].C1=CC=C2OC(C(=O)[O-])=CC(=O)C2=C1 KDBRTIVCOMURGG-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
' Hensikten med foreliggende oppfinnelse er å frem-legge en metode for fremstilling av forbindelser med struk-turformel The purpose of the present invention is to provide a method for the preparation of compounds with structural formula
hvor R betegner hydrogen, halogen, usubstituert lavalkyl, lavalkyl substituert med halogen, hydroksy eller lav alkoksy, hydroksy, hydroksy foretret med en substituert eller usubstituert alkylkjede med fra 3 til 5 c-atomer inklusive, eventuelt symmetrisk bundet via en eterbinding i den andre enden til en identisk kromenstruktur. A betegner hydrogen, en mettet eller umettet hydrokarbongruppe. en ammoniumgruppe, et alkali- eller jordalkalimetallatom. where R denotes hydrogen, halogen, unsubstituted lower alkyl, lower alkyl substituted with halogen, hydroxy or lower alkoxy, hydroxy, hydroxy etherified with a substituted or unsubstituted alkyl chain with from 3 to 5 carbon atoms inclusive, optionally symmetrically bound via an ether bond at the other end to an identical chromium structure. A denotes hydrogen, a saturated or unsaturated hydrocarbon group. an ammonium group, an alkali or alkaline earth metal atom.
Mer spesielt tilveiebringes en ny fremgangsmåte for ringslutning av en chromenring ut fra en umettet forbindelse med en åpen kjede, mer spesielt akrylaldehyd-derivater. More particularly, a new method for ring closure of a chromene ring from an unsaturated compound with an open chain, more particularly acrylaldehyde derivatives, is provided.
Et annet trekk ved foreliggende oppfinnelse er frem-stillingen av nye forbindelser med strukturen til 4-substituerte chromen-2-karboksylsyrer: Another feature of the present invention is the production of new compounds with the structure of 4-substituted chromene-2-carboxylic acids:
hvor A og K har ovenstående betydninger og k, og n2 Kan være like eller forskjellige og betegner hydrogen, lav alkyl, fenyl, where A and K have the above meanings and k, and n2 Can be the same or different and denote hydrogen, lower alkyl, phenyl,
fenyl substituert med halogen, hydroksy, lav alkyl, lavere halogenalkyl, lavere hydroksyalkyl eller lavere alkoksyalkyl. cykloalkyl, eller R^og- R2 sammen med det felles C-atomer kan danne et alicyklisk system med 5 eller 6 C-atomer, hvilke forbindelser med fordel benyttes i henhold til oppfinnelsens metode som mellomprodukter og selv oppviser farmakologisk aktive virkninger som østrogene og anti-østrogene reagenser. Med betegnelsen "lav alkyl" mener man en rettkjedet atomgruppe med fra 1 til 4 C-atomer, inklusive, som metyl, etyl, propyl og butyl. phenyl substituted with halogen, hydroxy, lower alkyl, lower haloalkyl, lower hydroxyalkyl or lower alkoxyalkyl. cycloalkyl, or R^ and R2 together with the common C atoms can form an alicyclic system with 5 or 6 C atoms, which compounds are advantageously used according to the method of the invention as intermediates and themselves exhibit pharmacologically active effects such as estrogenic and anti -estrogenic reagents. The term "lower alkyl" means a straight-chain atomic group with from 1 to 4 carbon atoms, inclusive, such as methyl, ethyl, propyl and butyl.
Med betegnelsen "lavere alkoksy" menes en rettkjedet C-atom gruppe med fra 1 til 4 C-atomer, inklusive, som metoksy, etoksy, propoksy og butoksy. The term "lower alkoxy" means a straight-chain C-atom group with from 1 to 4 C-atoms, inclusive, such as methoxy, ethoxy, propoxy and butoxy.
Med utrykket cykloalkyl menes en mettet karbon-ring med 5 eller 6 C-atomer, som cyklopentyl.og cykloheksyl. The expression cycloalkyl means a saturated carbon ring with 5 or 6 carbon atoms, such as cyclopentyl and cyclohexyl.
Med alkalimetall-atom betegnes natrium, kalium og litium, og med jordalkalimetall-atomer menes magnesium og kal-s ium. Alkali metal atoms mean sodium, potassium and lithium, and alkaline earth metal atoms mean magnesium and calcium.
Forbindelser med struktur I er kjente farmakologisk aktive stoffer hvorav de fleste finner anvendelse ved behandling av tilstander som skyldes antigen-antistoff-reaksjoner, særlig astmatilfeller. Compounds with structure I are known pharmacologically active substances, most of which are used in the treatment of conditions caused by antigen-antibody reactions, particularly asthma cases.
I henhold til foreliggende oppfinnelse tilveiebringes en metode for fremstilling av en forbindelse med formel According to the present invention, a method for producing a compound of formula is provided
hvor R har betydning som tidligere angitt og A^^betegner en mettet eller umettet hydrokarbongruppe, som består i at man ringslutter under egnede forhold et umettet aldehyd med formel where R has the meaning as previously indicated and A^^ denotes a saturated or unsaturated hydrocarbon group, which consists in ring closing under suitable conditions an unsaturated aldehyde with the formula
hvor R, R , R^og A^har de tidligere angitte bétydninger, where R, R , R^and A^ have the previously stated meanings,
hvorpå man oksyderer det nye mellomproduktet under egnede betingelser, hvilket mellomprodukt har formel after which the new intermediate is oxidized under suitable conditions, which intermediate has the formula
under dannelse av den ønskede forbindelse med formel III. while forming the desired compound of formula III.
, For å kunne fremstille disse forbindelser med formel I hvor A betegner hydrogen blir forbindelsene V med fordel hydrolysert før oksydasjon. , In order to be able to prepare these compounds of formula I where A denotes hydrogen, the compounds V are advantageously hydrolysed before oxidation.
For fremstilling av forbinbindelser med formel I hvor A betegner ammonium, alkali- eller jordalkalimetall-atomer, hydrolyseres forbindelsen V og saltdannes fortrinnsvis før oksydasjon. For the preparation of compounds of formula I where A denotes ammonium, alkali or alkaline earth metal atoms, the compound V is hydrolysed and salts are preferably formed before oxidation.
Når det foreligger frie hydroksyl-substituenter kan disse med fordel beskyttes ved egnede omsetninger, avhengig av de reagenser som brukes, og frigjøres ved å fjerne beksyt-telsesgruppene etter omsetningen. When free hydroxyl substituents are present, these can advantageously be protected by suitable reactions, depending on the reagents used, and released by removing the protecting groups after the reaction.
Foretring av en mulig fenolisk hydroksylgruppe gjør det mulig å fremstille bis-chromenforbindelser dannet av to chromenstrukturer som er symmetrisk bundet via en alkyj-ali-fatisk kjede med fra 3 til 5 C-atomer, eller en substituert alkylalifatisk kjede med fra 3 til 5 C-atomer. Etherification of a possible phenolic hydroxyl group makes it possible to prepare bis-chromene compounds formed by two chromene structures which are symmetrically linked via an alkyl-aliphatic chain with from 3 to 5 C atoms, or a substituted alkylaliphatic chain with from 3 to 5 C -atoms.
Aktivering av en fenolisk hydroksylgruppe kan skje før eller etter ringslutning, men gjennomføres i alle tilfel-le før den endelige oksydasjon. Activation of a phenolic hydroxyl group can take place before or after ring closure, but is carried out in all cases before the final oxidation.
Mer spesielt omsettes i henhold til foreliggende oppfinnelse derivater av alfa-substituerte aldehyder med formel IV i et egnet oppløsningsmiddel som toluen, benzen, etyleter, alifatiske hydrokarboner, med et egnet kondensasjons-reagens som metallisk natrium i nærvær av små mengder lavere alkylalkohol. More particularly, according to the present invention, derivatives of alpha-substituted aldehydes of formula IV are reacted in a suitable solvent such as toluene, benzene, ethyl ether, aliphatic hydrocarbons, with a suitable condensation reagent such as metallic sodium in the presence of small amounts of lower alkyl alcohol.
Reaksjonen forløper gradvis og gir høye utbytter av det tilsvarende chromenderivat V. The reaction proceeds gradually and gives high yields of the corresponding chromium derivative V.
Sistnevnte dannes, avhengig av formelen og utgangs-aldehydet samt det anvendte kondensasjonsmiddel, eventuelt som en blanding av cis- og trans-formene som kan skilles etter The latter is formed, depending on the formula and the starting aldehyde as well as the condensing agent used, possibly as a mixture of the cis and trans forms which can be distinguished by
kjente metoder.known methods.
De ringsluttede forbindelser som således fremstilles, som sådan eller i form av de tilsvarende frie 2-karboksylsyrer eller som de tilsvarende salter med ammonium eller med alkali- eller jordalkali-metaller, oksyderes ved hjelp av et egnet oksydasjonsmiddel som chromsyreanhydrid, ozon eller permanganat, hydrogen peroksyd eller osmium tetoksyd, fortrinnsvis blandet med periodsyre, og man får sluttforbin-delsen med formel I som separeres og renses på kjent måte. The ring-closed compounds thus produced, as such or in the form of the corresponding free 2-carboxylic acids or as the corresponding salts with ammonium or with alkali or alkaline earth metals, are oxidized by means of a suitable oxidizing agent such as chromic anhydride, ozone or permanganate, hydrogen peroxide or osmium tetoxide, preferably mixed with periodic acid, and the final compound with formula I is obtained, which is separated and purified in a known manner.
Ifølge en annen utførelse av foreliggende oppfinnelse fremlegges en ny metode for fremstilling av bis-chromen-derivater med formel According to another embodiment of the present invention, a new method for the production of bis-chromene derivatives with formula is provided
hvor A betegner hydrogen, en mettet eller umettet hydrokarbongruppe, ammonium, et alkali- eller jordalkali-metallatom, hvor en forbindelse med formel hvor A^har ovenstående betydning ringsluttet i egnet beskyttet form og deretter, for forbindelse VII, forbindes den ringsluttede forbindelse fortrinnsvis i 5-stilling med en identisk struktur gjennom en eventuelt beskyttet kjede where A represents hydrogen, a saturated or unsaturated hydrocarbon group, ammonium, an alkali or alkaline earth metal atom, where a compound of formula where A^ has the above meaning ring-closed in a suitable protected form and then, for compound VII, the ring-closed compound is preferably joined in 5-position with an identical structure through an optionally protected chain
derpå oksydert som sådan eller i form av den til- then oxidized as such or in the form of the added
svarende frie syre eller i form av det tilsvarende ammonium-, corresponding free acid or in the form of the corresponding ammonium,
alkali- eller jordalkalimetall-salt. Som et alternativ kan forbindelser med formel I hvor A betegner hydrogen, ammonium, alkali-metall eller jordalkalimetall, fremstilles ut fra forbindelser med formel alkali or alkaline earth metal salt. As an alternative, compounds of formula I where A denotes hydrogen, ammonium, alkali metal or alkaline earth metal can be prepared from compounds of formula
hvor R, R1 og R2har de tidligere angitte betydninger, ved omsetning med natriumhydroksyd eller tertiær alkylamin for fremstilling av det tilsvarende natrium- eller trialkylammo-nium-salt, som ringsluttes med eddiksyre anhydrid varmt ved temperaturer fra 100 til l40°C, eventuelt omdannes til ammonium-, alkali- eller jordalkali-metall-salt og derpå oksyderes til den ønskede forbindelse. where R, R1 and R2 have the previously stated meanings, by reaction with sodium hydroxide or tertiary alkylamine to produce the corresponding sodium or trialkylammonium salt, which is ring-closed with acetic anhydride hot at temperatures from 100 to 140°C, optionally converted to ammonium, alkali or alkaline earth metal salt and then oxidized to the desired compound.
De følgende eksempler skal illustrere foreliggende oppfinnelse uten å begrense den. The following examples shall illustrate the present invention without limiting it.
Eksempel 1.Example 1.
4- chromon- 2- karboksylsyre- metylester.4- chromone- 2- carboxylic acid methyl ester.
Fremstilling av cx- ( 2- metoksykarbonyl- metoksyfenyl)-kanelsyrealdehyd. Preparation of c- (2-methoxycarbonyl-methoxyphenyl)-cinnamic acid aldehyde.
Til en oppløsning av 55 g o-allylfenol i 250 ml vannfri aceton, settes 50 g vannfri kaliumkarbonat og 85 g etyl monobromacetat og blandingen kokes under tilbakeløp i 5 timer under røring. Det faste stoff filtreres fra og filterresten destilleres etter avdamping av acetonet i vakuum og gir 75 g 2-etoksykarbonylmetoksy-allylbenzen med kokepunkt 102 - 103°C/0.1 mm Hg (bad temperatur 125-130°C). To a solution of 55 g of o-allylphenol in 250 ml of anhydrous acetone, 50 g of anhydrous potassium carbonate and 85 g of ethyl monobromoacetate are added and the mixture is refluxed for 5 hours with stirring. The solid is filtered off and the filter residue is distilled after evaporating the acetone in vacuum to give 75 g of 2-ethoxycarbonylmethoxy-allylbenzene with a boiling point of 102 - 103°C/0.1 mm Hg (bath temperature 125-130°C).
22 gram 2-etoksykarbonylmetoksy-allylbenzen opplø-ses i 300 ml vannfri metylenklorid, blandingen avkjøles med aceton-tørris og ozoniseres, tillates oppvarming til romtemperatur, fryses på nytt i isbad, derpå tilsettes 80 g sink-pulver og gradvis en oppløsning inneholdende 40 ml eddiksyre og 10 ml vann, den resulterende blanding holdes under omrø-ring i 1 time og filtreres. Filterresten destilleres etter tørking på natriumsulfat, i vakuum, og gir 15 g 2-etoksykar- o 22 grams of 2-ethoxycarbonylmethoxy-allylbenzene are dissolved in 300 ml of anhydrous methylene chloride, the mixture is cooled with acetone-dry ice and ozonized, allowed to warm to room temperature, frozen again in an ice bath, then 80 g of zinc powder is added and gradually a solution containing 40 ml acetic acid and 10 ml of water, the resulting mixture is kept under stirring for 1 hour and filtered. The filter residue is distilled after drying on sodium sulfate, in a vacuum, and yields 15 g of 2-ethoxycaro- o
bonylmetoksy-fenylacetaldehyd med k.p. 135 C/0,2 mm (bad temperatur 155°C). 0,42 g kaliumhydroksyd oppløses i 0,5 ml vann og man tilsetter 10 ml etanol, 5,4 g benzsyrealdehyd og 1 ml 27 %- lg, vandig kaliumhydroksyd. Blandingen røres og av-kjøles med is - salt til en» blandingstemperatur på under 5°0. 1 g 2-etoksykarbonylmétoksy-fenylacetaldehyd tilsettes gradvis fulgt umiddelbart av 1 ml 27 %- ig oppløsning av kaliumhydroksyd. Man gjentar skiftevis tilsetningene av 1 g 2-e-toksykarbonylmetoksyfenylacetaldehyd og 1 ml 27 $-ig kalium-hydroksydoppløsning inntil det i alt er tilsatt 10 g forbindelse, derpå hensettes blandingen i 12 timer ved 0°C. 100 ml vann tilsettes og den vandige suspensjon ekstraheres med toluen. Den vandige oppløsning surgjøres med saltsyre og ekstraheres med etylacetat. Etylacetatoppløsningen vaskes med vann, tørkes på natriumsulfat og inndampes. Residumet oppløses i 400 ml vannfri metanol, 1 g p-toluensulfonsyre tilsettes og oppløsningen holdes kokende i 4 timer. Metanol destilleres av og man får et residum som oppløst i metanol leverer 5 g krystaller av (2-metoksykarbonylmetoksyfenyl)-kanelaldehyd, smeltepunkt 95 - 97°C. bonylmethoxy-phenylacetaldehyde with b.p. 135 C/0.2 mm (bath temperature 155°C). 0.42 g of potassium hydroxide is dissolved in 0.5 ml of water and 10 ml of ethanol, 5.4 g of benzaldehyde and 1 ml of 27% strength aqueous potassium hydroxide are added. The mixture is stirred and cooled with ice - salt to a mixture temperature of below 5°C. 1 g of 2-ethoxycarbonylmethoxy-phenylacetaldehyde is gradually added followed immediately by 1 ml of a 27% solution of potassium hydroxide. The additions of 1 g of 2-e-toxycarbonylmethoxyphenylacetaldehyde and 1 ml of 27% potassium hydroxide solution are repeated alternately until a total of 10 g of compound has been added, after which the mixture is allowed to stand for 12 hours at 0°C. 100 ml of water are added and the aqueous suspension is extracted with toluene. The aqueous solution is acidified with hydrochloric acid and extracted with ethyl acetate. The ethyl acetate solution is washed with water, dried over sodium sulfate and evaporated. The residue is dissolved in 400 ml of anhydrous methanol, 1 g of p-toluenesulfonic acid is added and the solution is kept boiling for 4 hours. Methanol is distilled off and a residue is obtained which, dissolved in methanol, delivers 5 g of crystals of (2-methoxycarbonylmethoxyphenyl)-cinnamaldehyde, melting point 95 - 97°C.
Til 0,35 g natrium dispergert i 2u.ml vannfri toluen settes 5 ml vannfri etyleter og deretter 1 ml oppløsning inneholdende 4,2 g cC-(2-metoksykarbonylmetoksyfenyl)-kånelaldehyd til ovenstående suspensjon som stadig holdes under omrøring, videre 9 ml vannfri toluen og 0,1 ml absolutt etanol ved ca. 40°C. Reaksjonsblandingen oppvarmes til 35 - 40°C til begyn-nende reaksjon og temperaturen senkes til ca. 20°C hvoretter restoppløsningen inneholdende -2-metoksykarbonylmetoksyfenyl-kanelaldehyd tilsettes langsomt. To 0.35 g of sodium dispersed in 2 u.ml of anhydrous toluene, 5 ml of anhydrous ethyl ether and then 1 ml of a solution containing 4.2 g of cC-(2-methoxycarbonylmethoxyphenyl)-canelaldehyde are added to the above suspension which is constantly kept under stirring, further 9 ml of anhydrous toluene and 0.1 ml absolute ethanol at approx. 40°C. The reaction mixture is heated to 35 - 40°C until the reaction starts and the temperature is lowered to approx. 20°C, after which the residual solution containing -2-methoxycarbonylmethoxyphenyl-cinnamaldehyde is added slowly.
Etter avsluttet tilsetning hensettes blandingen 12 timer ved romtemperatur, derpå tilsettes etylacetat og oppløs-ningen vaskes med vann og tørkes over natriumsulfat. Ved filtrering og inndampning får man et residum som oppløses i benzen og kromatograferes på aluminiumoksyd, hvilket gir 4-benzy-2 After the addition has been completed, the mixture is allowed to stand for 12 hours at room temperature, then ethyl acetate is added and the solution is washed with water and dried over sodium sulphate. Filtration and evaporation gives a residue which is dissolved in benzene and chromatographed on aluminum oxide, which gives 4-benzy-2
liden-A -chromen-2-karboksylsyremetylester.lidene-A -chromene-2-carboxylic acid methyl ester.
100 milligram 4-bensyliden-A -chromen-2-karboksyl-syremetylester som smelter ved 100 - 102°C oppløses i 6 ml 50 $-ig eddiksyre, oppløsningen oppvarmes til 50 - 60°C og en blanding inneholdende HOmg kromsyreanhydrid i 2,5 ml vann tilsettes. Reaksjonsblandingen hensettes til romtemperatur, 100 milligrams of 4-benzylidene-A -chromene-2-carboxylic acid methyl ester which melts at 100 - 102°C is dissolved in 6 ml of 50% acetic acid, the solution is heated to 50 - 60°C and a mixture containing HOmg of chromic anhydride in 2, 5 ml of water is added. The reaction mixture is allowed to reach room temperature,
fortynnet med vann og ekstraheres med etylacetat. Etylacetat-oppløsningen vaskes med vann, oppløsning av kallumbikarbonat og igjen med vann. Ved tørking på natriumsulfat, filtrering og inndamping får manmetylesteren av 4-chromon-2-karboksylsyre som krystallisert - fra metanol smelter ved 121-122°C. diluted with water and extracted with ethyl acetate. The ethyl acetate solution is washed with water, calcium bicarbonate solution and again with water. By drying on sodium sulphate, filtering and evaporating, the manmethyl ester of 4-chromone-2-carboxylic acid is obtained as crystallized - from methanol melting at 121-122°C.
Eksempel 2.Example 2.
4- chromon- 2- karboksylsyre.4- chromone- 2- carboxylic acid.
2,8 g 4-benzyliden-A -chromen-2-karboksylsyre-metylester fremstilt som ovenfor behandles med 50 ml etanol og deretter en oppløsning inneholdende 0,5 g natriumhydroksyd i 20 ml vann. Oppløsningen varmes feil 50 - 60°C i 1 time og den dannede oppløsning konsentreres i vakuum til et lite volum. 2.8 g of 4-benzylidene-A-chromene-2-carboxylic acid methyl ester prepared as above is treated with 50 ml of ethanol and then a solution containing 0.5 g of sodium hydroxide in 20 ml of water. The solution is heated to 50 - 60°C for 1 hour and the resulting solution is concentrated in vacuo to a small volume.
Den vandige oppløsning ekstraheres med etylacetat og surgjøres med saltsyre til 2,1 g 4-benzyliden-A 2-chromen-2-karbbksylsyre som ved behandling med kromsyreanhydrid gir 4-chromon-2-karboksylsyre The aqueous solution is extracted with ethyl acetate and acidified with hydrochloric acid to 2.1 g of 4-benzylidene-A 2-chromene-2-carboxylic acid, which on treatment with chromic anhydride gives 4-chromone-2-carboxylic acid
3,<1>g -(2-metoksykarbonylmetoksyfenyl)-kanelalde-hyd fremstilt som beskrevet i eksempel 1 behandles med 50 ml etanol og derpå tilsettes en oppløsning som inneholder 0,5 g natriumhydroksyd i 20 ml vann. Blandingen oppvarmes til 50 - 60°C i 1 timerog den dannede oppløsning konsentreres i vakuum til et lite volum, derpå tilsetter man 30 ml vann og blandingen ekstraheres med etylacetat. Den vandige oppløsning sur-gjøres med saltsyre og ekstraheres med etylacetat. Etylace-tatoppløsningen tørkes og inndampes og til residumet settes 1 g trietylamin og 3 g eddiksyreanhydrid. Blandingen oppvarmes til 105 - 110°C i noen timer, derpå avkjøles til romtemperatur og overskuddet av eddiksyreanhydrid avdampes i vakuum, man tilsetter vann og is og blandingen surgjøres med saltsyre for utfelling av 4-benzyliden-A 2-chromen-2-karboksylsyre som behandles med kromsyreanhydrid gir 4-chromon-2-karboksylsyre. 3.<1>g of -(2-methoxycarbonylmethoxyphenyl)-cinnamaldehyde prepared as described in example 1 is treated with 50 ml of ethanol and then a solution containing 0.5 g of sodium hydroxide in 20 ml of water is added. The mixture is heated to 50 - 60°C for 1 hour and the resulting solution is concentrated in vacuo to a small volume, then 30 ml of water is added and the mixture is extracted with ethyl acetate. The aqueous solution is acidified with hydrochloric acid and extracted with ethyl acetate. The ethylacetate solution is dried and evaporated and 1 g of triethylamine and 3 g of acetic anhydride are added to the residue. The mixture is heated to 105 - 110°C for a few hours, then cooled to room temperature and the excess of acetic anhydride is evaporated in vacuo, water and ice are added and the mixture is acidified with hydrochloric acid to precipitate 4-benzylidene-A 2-chromene-2-carboxylic acid which treated with chromic anhydride gives 4-chromone-2-carboxylic acid.
Eksempel 3-Example 3-
4- chromon- 2- karboksylsyre- natriu. msalt.4- chromone- 2- carboxylic acid sodium. msalt.
1,3 g 4-benzyliden-A 2-chromen-2-karboksylsyre fremstilt som tidligere beskrevet oppløses i en oppløsning av 25 ml 0,2 N natriumhydroksyd. Blandingen avkjøles til lav temperatur og man innføres 5,2 mol ozon. Etter avsluttet tilsetning behandles oppløsningen med Raney-nikkel og filtreres. Den 1.3 g of 4-benzylidene-A 2-chromene-2-carboxylic acid prepared as previously described is dissolved in a solution of 25 ml of 0.2 N sodium hydroxide. The mixture is cooled to a low temperature and 5.2 mol of ozone are introduced. After the addition is complete, the solution is treated with Raney nickel and filtered. It
filtrerte oppløsning ekstraheres med'etyleter og vannoppløs-ningen konsentreres i vakuum hvorpå etanol tilsettes flere ganger. Ved avkjøling får man 0.8 g 4-chromon-2-karboksylsyre-natriumsalt. filtered solution is extracted with ethyl ether and the water solution is concentrated in vacuum, after which ethanol is added several times. On cooling, 0.8 g of 4-chromone-2-carboxylic acid sodium salt is obtained.
Eksempel 4. Example 4.
6- metyl- 4- chromon- 2- karboksylsyre- metylester. 6- methyl- 4- chromone- 2- carboxylic acid methyl ester.
Fremstilling av °t- ( 5- metyl- 2- metoksykarbonylmetok-syfenyl)- kanelaldehyd. Preparation of °t-(5-methyl-2-methoxycarbonylmethoxyphenyl)-cinnamaldehyde.
Operasjonen er som beskrevet i eksempel 1: ut fra 11 g o-allyl-p-cresol (j. Org. Chem. 5, 212) som omsettes med etylbromacetat til 15 g 5-metyl-2-etoksykarbonylmetoksyallyl-benzen hvorav man tar 11 g 5-metyl-2-etoksykarbonylmetoksy-allylbenzen som ozoniseres og gir 7 g 5-metyl-2-etoksykar-bonylmetoksyfehyl-acetaldehyd. Ved kondensasjon av 10 g 5-,metyl-2-etoksykarbonylmetoksyfenylacetaldehyd med benzosyre-aldehyd og forestring med metanol får man 6 g (5-metyl-2-metoksykarbonyImetoksyfenyl)-kanelaldehyd. The operation is as described in example 1: starting from 11 g of o-allyl-p-cresol (j. Org. Chem. 5, 212) which is reacted with ethyl bromoacetate to 15 g of 5-methyl-2-ethoxycarbonylmethoxyallyl-benzene from which 11 g of 5-methyl-2-ethoxycarbonylmethoxy-allylbenzene which is ozonized to give 7 g of 5-methyl-2-ethoxycarbonylmethoxyphenylacetaldehyde. Condensation of 10 g of 5-,methyl-2-ethoxycarbonylmethoxyphenylacetaldehyde with benzoic aldehyde and esterification with methanol yields 6 g of (5-methyl-2-methoxycarbonylmethoxyphenyl)cinnamaldehyde.
Man går frem som i eksempel 1 og 6 g (5-metyl-2-metoksy-karbonylmetoksyfenyl)-kanelaldehyd ringsluttes og gir 3,5 g 6-metyl-4-benzyliden-A -chromen-2-karboksylsyremetylester som etter oksydasjon med kromsyreanhydrid gir 6-metyl-4-chromen-2-karboksylsyremetylester. One proceeds as in example 1 and 6 g of (5-methyl-2-methoxy-carbonylmethoxyphenyl)-cinnamaldehyde is ring-closed to give 3.5 g of 6-methyl-4-benzylidene-A-chromene-2-carboxylic acid methyl ester which after oxidation with chromic anhydride gives 6-methyl-4-chromene-2-carboxylic acid methyl ester.
Eksempel 5»Example 5»
Dimetylester av 1, 3~ bis( 2- karboksychromon- 5- yloksy)-2- acetoksy propan. 30 g 2-allylresorcinol fremstilt som angitt i Béil-stein (fjerde opplag 6, 5020) behandles med 200 ml aceton og 18 g etylkloracetat og 20 g kaliumbikarbonat tilsettes. Blandingen kokes under tilbakeløp i 20 timer omtrent, derpå fjernes acetonet ved destillasjon, inndampningsresten tas opp med metylenklorid og det organiske skjiktet ekstraheres flere ganger med vann. Oppløsningen av metylenklorid tørkes og 2-etoksykarbonylmetoksy-6-hydroksyallylbenzen høyvakuum-destilleres ved ca. 130°C. Produktet viser Rf lik ca. 0,46 (benzen: etyleter = 9:1). Dimethyl ester of 1,3~ bis(2-carboxychromon-5-yloxy)-2-acetoxy propane. 30 g of 2-allylresorcinol prepared as indicated in Béil-stein (fourth edition 6, 5020) is treated with 200 ml of acetone and 18 g of ethyl chloroacetate and 20 g of potassium bicarbonate are added. The mixture is refluxed for approximately 20 hours, then the acetone is removed by distillation, the evaporation residue is taken up with methylene chloride and the organic layer is extracted several times with water. The solution of methylene chloride is dried and 2-ethoxycarbonylmethoxy-6-hydroxyallylbenzene is high-vacuum distilled at approx. 130°C. The product shows Rf equal to approx. 0.46 (benzene: ethyl ether = 9:1).
Til 47,25 g 2-etoksykarbonylmetoksy-6-hydroksyallyl-benzen oppløst i 100 ml vannfri etylalkohol settes en oppløs-ning av 6,8 g natriumetylat i 100 ml vannfri etylalkohol og videre 9,5 g epiklorhydrin. Blandingen kokes under tilbakeløp i l6 timer, etylalkoholen fjernes og resten tas opp med etylacetat hvorpå den organiske oppløsning ekstraheres med vann og inndampes. 2-etoksykarbonylmetoksy-6-hydroksyallylbenzen som ikke har reagert avdestilleres i høyvakuum og man får 1,3-bis(2-ally1-3-etoksykarbonylmetoksyfenoksy)-2-hydroksy-propan med Rf ca 0,27 (benzen:etyleter = 9:1). To 47.25 g of 2-ethoxycarbonylmethoxy-6-hydroxyallyl-benzene dissolved in 100 ml of anhydrous ethyl alcohol is added a solution of 6.8 g of sodium ethylate in 100 ml of anhydrous ethyl alcohol and further 9.5 g of epichlorohydrin. The mixture is boiled under reflux for 16 hours, the ethyl alcohol is removed and the residue is taken up with ethyl acetate, after which the organic solution is extracted with water and evaporated. Unreacted 2-ethoxycarbonylmethoxy-6-hydroxyallylbenzene is distilled off under high vacuum and 1,3-bis(2-ally1-3-ethoxycarbonylmethoxyphenoxy)-2-hydroxy-propane is obtained with Rf approx. 0.27 (benzene:ethyl ether = 9: 1).
Til 40 g 1,3-bis-(2-allyl-3-etoksykarbonylmetoksy-fenoksy)-2-hydroksypropan oppløst i 40 ml vannfri pyridin settes 100 g vannfri eddiksyre og blandingen holdes 12 ti- To 40 g of 1,3-bis-(2-allyl-3-ethoxycarbonylmethoxy-phenoxy)-2-hydroxypropane dissolved in 40 ml of anhydrous pyridine is added 100 g of anhydrous acetic acid and the mixture is kept for 12 ti-
mer ved romtemperatur. Den inndampes under vakuum, inndampningsresten oppløses i etylacetat og oppløsningen vaskes med 2N saltsyre, vann og inndampes til tørrhet. Man får et residum av 1,3-bis-(2-allyl-3-etoksykarbonylmetoksyfenoksy)-2-acetoksypropan som har Rf ca. 0,47 (benzen:etyleter = 9:1)-40 g 1,3-bis-(2-allyl-3-etoksykarbonylmetoksyfenok-sy )-2-acetoksypropan oppløst i 400 ml vannfri metylenklorid mettes med ozon idet blandingen holdes i et bad av aceton og tørris. Man tilsetter 120 g sink og en blanding av 60 ml eddiksyre og 15 ml vann. Oppløsningen røres i noen timer, filtreres og vaskes med kaliumbikarbonatoppløsning og med vann. Etter inndampning av oppløsningsmiddelet får man 1,3-bis-(2-etylaldehyd-3-etoksykarbonyImetoksyfenoksy)-2-acetoksypropan som har Rf ca. 0,5 (benzen:etyleter = 1:1). more at room temperature. It is evaporated under vacuum, the evaporation residue is dissolved in ethyl acetate and the solution is washed with 2N hydrochloric acid, water and evaporated to dryness. A residue of 1,3-bis-(2-allyl-3-ethoxycarbonylmethoxyphenoxy)-2-acetoxypropane is obtained which has Rf approx. 0.47 (benzene:ethyl ether = 9:1)-40 g of 1,3-bis-(2-allyl-3-ethoxycarbonylmethoxyphenoxy)-2-acetoxypropane dissolved in 400 ml of anhydrous methylene chloride is saturated with ozone while keeping the mixture in a bath of acetone and dry ice. 120 g of zinc and a mixture of 60 ml of acetic acid and 15 ml of water are added. The solution is stirred for a few hours, filtered and washed with potassium bicarbonate solution and with water. After evaporation of the solvent, 1,3-bis-(2-ethylaldehyde-3-ethoxycarbonylImethoxyphenoxy)-2-acetoxypropane is obtained, which has Rf approx. 0.5 (benzene:ethyl ether = 1:1).
Til en oppløsning av 25 g kaliumhydroksyd i 150 ml vann tilsettes 500 ml etylalkohol. Blandingen avkjøles til ca. 0°C og man tilsetter langsomt en blanding av 33 g 1,3-bis-(2-etylaldehyd-3-etoksykarbonyImetoksyfenoksy)-2-acetok-sypropan og 64 g benzosyrelaldehyd. Oppløsningen hensettes i 12 timer og man tilsetter deretter 50 g kaliumbikarbonat. Blandingen inndampes i vakuum og oppløsningsmiddelet og overskuddet av benzaldehyd fjernes. Avdampningsresten tas opp med 100 ml vann og ekstraheres med toluen, vannoppløsningen sur-gjøres deretter med saltsyre og ekstraheres med etylacetat og ekstraktet forestres med metanol og paratoluensulfonsyre til 1,3-bis-(3-metoksykarbonyImetoksy-2-benzyliden-etylaldehyd-fenoksy)-2-hydroksypropan med R^ ca. 0,9 (etylacetat).' 45 g 1,3-bis-(3-metoksykarbonylmetoksy-2-benzyliden-etylaldehydfenoksy)-2-hydroksypropan oppløses i 90 ml vannfri toluen og 1 ml vannfri etylalkohol og denne oppløsningen set^tes gradvis til en suspensjon av 3,5 g natrium i 20 ml vann fri toluen og 50 ml vannfri etyleter. Blandingen holdes mel-lom 35 og 40°C inntil tilsetningen er fullstendig. Man hen-setter den ved romtemperatur i 12 timer etter avdamping av oppløsningsmiddelet og tilsetter metylenklorid og 2N saltsyre. Metylenkloridoppløsningen tørkes, og man får dimetylesteren av 1,3-bis-(2-karboksy-4-benzilidenchromen-5-yloksy)-2-hydrok-sypropan. 500 ml of ethyl alcohol is added to a solution of 25 g of potassium hydroxide in 150 ml of water. The mixture is cooled to approx. 0°C and a mixture of 33 g of 1,3-bis-(2-ethylaldehyde-3-ethoxycarbonylImethoxyphenoxy)-2-acetoxypropane and 64 g of benzosylaldehyde is slowly added. The solution is allowed to stand for 12 hours and 50 g of potassium bicarbonate is then added. The mixture is evaporated in vacuo and the solvent and excess benzaldehyde are removed. The evaporation residue is taken up with 100 ml of water and extracted with toluene, the water solution is then acidified with hydrochloric acid and extracted with ethyl acetate and the extract is esterified with methanol and paratoluenesulfonic acid to 1,3-bis-(3-methoxycarbonylImethoxy-2-benzylidene-ethylaldehyde-phenoxy) -2-hydroxypropane with R^ approx. 0.9 (ethyl acetate).' 45 g of 1,3-bis-(3-methoxycarbonylmethoxy-2-benzylidene-ethylaldehydephenoxy)-2-hydroxypropane is dissolved in 90 ml of anhydrous toluene and 1 ml of anhydrous ethyl alcohol and this solution is gradually added to a suspension of 3.5 g of sodium in 20 ml anhydrous toluene and 50 ml anhydrous ethyl ether. The mixture is kept between 35 and 40°C until the addition is complete. It is left at room temperature for 12 hours after evaporation of the solvent and methylene chloride and 2N hydrochloric acid are added. The methylene chloride solution is dried, and the dimethyl ester of 1,3-bis-(2-carboxy-4-benzylidenechromen-5-yloxy)-2-hydroxypropane is obtained.
Til 10 g 1,3-bis-(2-karboksy-4-benzilidenchromen-5-yloksy)-2-hydroksypropan oppløst i 30 ml vannfri pyridin settes 25 g eddiksyreanhydrid. Blandingen hensettes ved romtemperatur i 12 timer, inndampes i vakuum og residumet oppløses i metylenklorid. Oppløsningen vaskes med 2N saltsyre, vann og deretter tørkes den til 1,3-bis-(2-karboksy-4-benzilidenchro-men-5-yloksy)-2-acetoksypropandimetylester. 25 g of acetic anhydride are added to 10 g of 1,3-bis-(2-carboxy-4-benzylidenechromen-5-yloxy)-2-hydroxypropane dissolved in 30 ml of anhydrous pyridine. The mixture is left at room temperature for 12 hours, evaporated in vacuo and the residue dissolved in methylene chloride. The solution is washed with 2N hydrochloric acid, water and then dried to 1,3-bis-(2-carboxy-4-benzylidenechromen-5-yloxy)-2-acetoxypropane dimethyl ester.
10 g 1,3-bis-(2-karboksy-4-benzilidenchromen-5-y-loksy)-2-acetoksypropandimetylester behandles i 300 ml 50 $-ig eddiksyre, oppvarmes til 50 - 60°C og tilsettes derpå en opp-løsning av 9 g kromsyreanhydrid i 200 ml vann. Blandingen oppvarmes til romtemperatur, fortynnes med vann og ekstraheres 10 g of 1,3-bis-(2-carboxy-4-benzylidenechromene-5-yl-loxy)-2-acetoxypropane dimethyl ester is treated in 300 ml of 50 µg acetic acid, heated to 50 - 60°C and then added a solution of 9 g of chromic anhydride in 200 ml of water. The mixture is warmed to room temperature, diluted with water and extracted
med metylenklorid. Metylenkloridoppløsningen vaskes vann, kaliumbikarbonat og igjen med vann. Etter tørking og fjerning av dimetylesteren får man 1,3-bis-(2-karboksychromon-5-ylok-sy)-2-acetoksypropan som smelter ved ca. 220°C, R^0,55 (etylacetat). with methylene chloride. The methylene chloride solution is washed with water, potassium bicarbonate and again with water. After drying and removal of the dimethyl ester, 1,3-bis-(2-carboxychromon-5-yloxy)-2-acetoxypropane is obtained which melts at approx. 220°C, R = 0.55 (ethyl acetate).
Forsåpning av l,3-bis-(2-karboksychromon-5-yloksy)-2-acetoksypropandimetylester gir 1,3-bis-(karboksychromon-5-yloksy)-2-hydroksypropan som kan forestres med f or .--eksempel metylalkohol til en 1,3-bis(2-karboksychromon-5-yloksy)-2-hydroksypropandimetylester. Saponification of 1,3-bis-(2-carboxychromon-5-yloxy)-2-acetoxypropane dimethyl ester yields 1,3-bis-(carboxychromon-5-yloxy)-2-hydroxypropane which can be esterified with for example methyl alcohol to a 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane dimethyl ester.
Eksempel 6. Example 6.
1, 3- bis-( 2- karboksychromon- 5- yloksy)- 2- hydroksypro-pandinatriumsalt. 32 g 1,3-bis-(2-karboksy-4-benzilidenchromen-5-ylok-sy)-2-hydroksypropan fremstilt ved forsåpning av den tilsvarende dimetylester som ovenfor beskrevet behandles med pyridin og eddiksyreanhydrid og gir 1,3-bis-(2-karboksy-4-benzi-lidenchromen-5-yloksy)-2-acetoksypropan. 33 g 1,3-bis-(2-karboksy-4-benzilidenchromen-5-yloksy)-2-acetoksypropan behandles i 500 ml 0,2N natriumhy-droksydoppløsning og avkjøles. Den avkjølte oppløsning be handles med teoretisk mengde ozon og etter avsluttet tilsetning påfylles Raney-nikkel og man filtrerer. Oppløsningen ekstraheres med etyleter og til den vandige oppløsning tilsettes 4,4 g natriumbikartaonat. Av den vandige oppløsning får man ved konsentrering 1,3-bis-(2-karboksychromon-5-yloksy) -2-hydroksypropandinatriumsalt. 1, 3- bis-(2- carboxychromon-5- yloxy)- 2- hydroxypropane sodium salt. 32 g of 1,3-bis-(2-carboxy-4-benzylidenechromen-5-yloxy)-2-hydroxypropane produced by saponification of the corresponding dimethyl ester as described above is treated with pyridine and acetic anhydride and gives 1,3-bis- (2-Carboxy-4-benzylidenchromen-5-yloxy)-2-acetoxypropane. 33 g of 1,3-bis-(2-carboxy-4-benzylidenechromen-5-yloxy)-2-acetoxypropane are treated in 500 ml of 0.2N sodium hydroxide solution and cooled. The cooled solution is treated with a theoretical amount of ozone and, after the addition has been completed, Raney nickel is topped up and filtered. The solution is extracted with ethyl ether and 4.4 g of sodium bicarbonate is added to the aqueous solution. The aqueous solution is concentrated to obtain 1,3-bis-(2-carboxychromon-5-yloxy)-2-hydroxypropane disodium salt.
Claims (11)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21515/74A IT1044793B (en) | 1974-04-17 | 1974-04-17 | PREPARATION OF PIRANIC PASTIAL STRUCTURE COMPOUNDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO751362L true NO751362L (en) | 1975-10-20 |
Family
ID=11182945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO751362A NO751362L (en) | 1974-04-17 | 1975-04-16 |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS50137981A (en) |
| BG (1) | BG24672A3 (en) |
| DD (1) | DD121935A5 (en) |
| DE (1) | DE2516623A1 (en) |
| DK (1) | DK165975A (en) |
| ES (1) | ES436627A1 (en) |
| FI (1) | FI751145A7 (en) |
| FR (1) | FR2303010A1 (en) |
| IL (1) | IL47083A0 (en) |
| IN (1) | IN142206B (en) |
| IT (1) | IT1044793B (en) |
| LU (1) | LU72297A1 (en) |
| NL (1) | NL7504598A (en) |
| NO (1) | NO751362L (en) |
| RO (1) | RO72847A (en) |
| SE (1) | SE7504342L (en) |
| ZA (1) | ZA752432B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3722886A1 (en) * | 1987-07-10 | 1989-01-19 | Basf Ag | METHOD FOR THE PRODUCTION OF (ALPHA), SS-SUBSTITUTED ACROLEINS AND NEW SUBSTITUTED ACROLEINS |
| KR960008645B1 (en) * | 1993-09-08 | 1996-06-28 | 동국제약 주식회사 | Preparation of ortho-isopropylized phenol derivatives |
| US20230220298A1 (en) * | 2020-06-12 | 2023-07-13 | Firmenich Sa | Enol ether properfume |
-
1974
- 1974-04-17 IT IT21515/74A patent/IT1044793B/en active
-
1975
- 1975-04-14 IL IL47083A patent/IL47083A0/en unknown
- 1975-04-14 IN IN740/CAL/75A patent/IN142206B/en unknown
- 1975-04-15 RO RO7581993A patent/RO72847A/en unknown
- 1975-04-15 SE SE7504342A patent/SE7504342L/en unknown
- 1975-04-15 FR FR7511642A patent/FR2303010A1/en not_active Withdrawn
- 1975-04-16 DE DE19752516623 patent/DE2516623A1/en active Pending
- 1975-04-16 ZA ZA00752432A patent/ZA752432B/en unknown
- 1975-04-16 ES ES436627A patent/ES436627A1/en not_active Expired
- 1975-04-16 LU LU72297A patent/LU72297A1/xx unknown
- 1975-04-16 NO NO751362A patent/NO751362L/no unknown
- 1975-04-17 JP JP50045909A patent/JPS50137981A/ja active Pending
- 1975-04-17 NL NL7504598A patent/NL7504598A/en unknown
- 1975-04-17 DK DK165975A patent/DK165975A/en not_active IP Right Cessation
- 1975-04-17 FI FI751145A patent/FI751145A7/fi not_active Application Discontinuation
- 1975-04-17 DD DD185515A patent/DD121935A5/xx unknown
- 1975-04-17 BG BG029697A patent/BG24672A3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL47083A0 (en) | 1975-06-25 |
| IT1044793B (en) | 1980-04-21 |
| NL7504598A (en) | 1975-10-21 |
| FI751145A7 (en) | 1975-10-18 |
| LU72297A1 (en) | 1975-08-20 |
| DD121935A5 (en) | 1976-09-05 |
| ZA752432B (en) | 1976-09-29 |
| DK165975A (en) | 1975-10-18 |
| SE7504342L (en) | 1975-10-20 |
| DE2516623A1 (en) | 1975-10-23 |
| FR2303010A1 (en) | 1976-10-01 |
| RO72847A (en) | 1983-07-07 |
| JPS50137981A (en) | 1975-11-01 |
| ES436627A1 (en) | 1977-05-01 |
| BG24672A3 (en) | 1978-04-12 |
| IN142206B (en) | 1977-06-11 |
| RO72847B (en) | 1983-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5473075A (en) | Diastereomer salt of optically active quinolinemevalonic acid | |
| NO178764B (en) | Process for the preparation of oxetanones | |
| US3484445A (en) | Derivatives of chromone-2-carboxylic acid | |
| JPS6240358B2 (en) | ||
| NO140977B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINO-1,4-DIHYDROPYRIDINES | |
| JPH0368026B2 (en) | ||
| US3362988A (en) | Alkanoylnaphthyloxy-carboxylic acids | |
| FRIED et al. | STUDIES ON LACTONES RELATED TO THE CARDIAC AGLYCONES. VI. THE ACTION OF DIAZOMETHANE ON CERTAIN DERIVATIVES OF α-PYRONE | |
| NO751362L (en) | ||
| US4153791A (en) | 3-Carboxy-4 hydroxyphenylthioacetmorpholide | |
| HU191824B (en) | Process for producing new pyridine and pyrimidine derivatives utilizable as intermediares producing antiflogistic and immunkregulating compounds | |
| US2993056A (en) | Production of the 1-6-lactone of 6-hydroxy-8-acetoxy-octanoic acid | |
| Singh et al. | Acid-catalyzed decarboxylation of glycidic acids." Abnormal" products | |
| EP0010761B1 (en) | Process for preparing 4-hydroxy-2-cyclopenten-i-ones, 2-methyl-2,5-dimethoxy-2,5-dihydrofurans and a process for their preparation | |
| JP3647455B2 (en) | Method for producing 3-isoxazolecarboxylic acid | |
| US3890304A (en) | 7{60 -carbam oyl-17-hydroxy-3-oxo-17{60 -pregn-4-ene-21-carboxylic acid {65 -lactone and related compounds | |
| JP2612161B2 (en) | Method for producing dibenzothiepine derivatives | |
| JPS609490B2 (en) | Production method of cyclohexanedione-(1,3) | |
| US4166061A (en) | Use of cyclic esters to prepare 2,3-dichloro-4-(2-thenoyl)phenoxyacetic acid | |
| JPS60142938A (en) | Ketal of 2-halo-1-(6'-methoxy-2'-naphthyl)-propan-1-one | |
| US2732389A (en) | I-methyl-z-carboxy-y-oxy derivatives of | |
| US5936120A (en) | Deoxygossylic compounds | |
| NO750877L (en) | ||
| US4259512A (en) | Method of synthesis for a chemical precursor to strigol | |
| US4723038A (en) | Process for preparing seed germinating stimulants |